T. Nywening
Immunology · 2014–2016
A researcher in the Science corpus: 3 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Immunology — 34 citations into it
- Molecular Biology — 12 citations into it
Whom T. Nywening trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts T. Nywening overall
Papers from T. Nywening's perspective
Ordered by how strongly the researchers T. Nywening trusts endorse each paper. Same corpus, a different order for every researcher.
- Trophic macrophages in development and disease (Nature reviews. Immunology)
- Alternative activation of macrophages: an immunologic functional perspective. (Annual Review of Immunology)
- Oncogenic Kras-induced GM-CSF production promotes the development of pancreatic neoplasia (Cancer Cell)
- Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes. (Cancer Research)
- CSF-1R inhibition alters macrophage polarization and blocks glioma progression (Nature Medicine)
- Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma (New England Journal of Medicine)
- Macrophages, innate immunity and cancer: balance, tolerance, and diversity. (Current Opinion in Immunology)
- Myeloid-derived-suppressor cells as regulators of the immune system (Nature reviews. Immunology)
- Hallmarks of cancer: the next generation. (Cell)
- Immunity, Inflammation, and Cancer (Cell)
Their papers
- Targeting Focal Adhesion Kinase Renders Pancreatic Cancers Responsive to Checkpoint Immunotherapy (2016) — 910 citations
- Phase 1b study targeting tumour associated macrophages with CCR2 inhibition plus FOLFIRINOX in locally advanced and borderline resectable pancreatic cancer (2016) — 664 citations
- CSF1/CSF1R Blockade Reprograms Tumor-Infiltrating Macrophages and Improves Response to T Cell Checkpoint Immunotherapy in Pancreatic Cancer Models (2014) — 1,178 citations